Turner
 L. Atypical mycobacterial infections in ophthalmology. Trans Am Ophthalmol Soc. 1970;68667- 729
Wallace
 RJ
 Jr, Swenson
 JM, Silcox
 VA, Good
 RC, Tschem
 JA, Stone
 MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983;5657- 677
Not Available,
 Mycobacterium chelonei infections following eye surgery-Texas. MMWR Morb Mortal Wkly Rep. 1983;32591- 597
Ford
 JG, Huang
 AJW, Plugfelder
 SC, Alfonso
 EC, Forster
 RK, Miller
 D. Nontuberculous mycobacterial keratitis in South Florida. Ophthalmology. 1998;1051652- 1658
Hwang
 DG, Biswell
 R. Ciprofloxacin therapy of Mycobacterium chelonae keratitis. Am J Ophthalmol. 1993;115114- 115
Roussel
 TJ, Stern
 WH, Goodman
 DF, Whitcher
 J. Postoperative myobacterial endophthalmitis. Am J Ophthalmol. 1989;107403- 407
Robin
 JB, Beatty
 RF, Dunn
 S.
 et al.  Mycobacterium chelonei keratitis after radial keratotomy. Am J Ophthalmol. 1986;10272- 79
Lazar
 M, Nemet
 R, Bracha
 R, Campus
 A. Mycobacterium fortuitum keratitis. Am J Ophthalmol. 1974;78530- 532
Newman
 PE, Goodman
 RA, Waring
 GO
 III.
 et al.  A cluster of cases of Mycobacterium chelonei keratitis associated with outpatient office procedures. Am J Ophthalmol. 1984;97344- 348
Khooshabeh
 R, Grange
 JM, Yates
 MD, McCartney
 ACE, Casey
 TA. A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye and orbit. Tuber Lung Dis. 1994;75377- 382
Brancato
 R, Carones
 F, Venturi
 E, Cavallero
 A, Gesu
 G. Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy. Arch Ophthalmol. 1997;1151316- 1318
Bullington
 RH, Lanier
 JD, Font
 RL. Nontuberculous mycobacterial keratitis: report of 2 cases and review of the literature. Arch Ophthalmol. 1992;110519- 524
Reviglio
 V, Rodriguez
 ML, Ricotti
 GS, Paradello
 M, Juna
 JD, Juarez
 CP. Mycobacterium chelonae keratitis following laser in situ keratomileusis. J Refract Surg. 1998;14357- 360
Hsiao
 CH, Chen
 JJ, Huang
 SC, Ma
 HK, Chen
 PY, Tsai
 RJ. Intrascleral dissemination of infectious scleritis following pterygium excision. Br J Ophthalmol. 1998;8229- 34
Huang
 SC, Soong
 HK, Chang
 JS, Liang
 YS. Non-tuberculous mycobacterial keratitis: a study of 22 cases. Br J Ophthalmol. 1996;80962- 968
Dugel
 PU, Holland
 GN, Brown
 HH.
 et al.  Mycobacterium fortuitum keratitis. Am J Ophthalmol. 1988;105661- 669
He
 F, Luh
 K. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis. Ophthalmology. 1998;105269- 272
Pavan
 PR, Menowsky
 MM, Arango
 JL, Livington
 PG. Significance of positive vitreous cassette cultures. Vitreous Soc Online J [serial online]. September1999;[
posted June 20, 2000]; 2(1) [11 screens]. Available at:
http://www.vitreoussociety.org. Accessibility verified June 26, 2000
He
 FR, Wang
 IJ. Comparison of topical antibiotics for treating Mycobacterium chelonae keratitis in a rabbit model. Curr Eye Res. 1998;17478- 482
Collins
 CH, Uttley
 AH. In vitro susceptibility of mycobacteria to ciprofloxacin. J Antimicrob Chemother. 1985;16575- 580
Lin
 R, Holland
 GN, Helm
 CJ.
 et al.  Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model. Am J Ophthalmol. 1994;117657- 662
Stevens
 RK, Holland
 GN, Paschal
 JP.
 et al.  Mycobacterium fortuitum keratitis: a comparison of topical ciprofloxacin and amikacin in an animal model. Cornea. 1992;11500- 504
Wallace
 RJ
 Jr, Bedsole
 G, Sumter
 G.
 et al.  Activity of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single drug therapy. Antimicrob Agents Chemother. 1990;3465- 70
Driscoll
 MS, Tyring
 SK. Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol. 1997;36495- 6
Mames
 RN, Friedman
 SM, Stinson
 WG, Margo
 CE. Positive vitreous cultures from eyes without signs of infectious endophthalmitis. Ophthalmic Surg Lasers. 1997;28365- 369